Active Ingredient: Indinavir
Indinavir is indicated in combination with antiretroviral nucleoside analogues for the treatment of HIV-1 infected adults.
For this indication, competent medicine agencies globally authorize below treatments:
Oral
1,500 - 1,500 mg per m² of body surface area (BSA)
From 500 To 500 mg per m² of body surface area (BSA) 3 time(s) per day every day
Children above the age of 4 years.
For optimal absorption, indinavir should be administered without food but with water 1 hour before or 2 hours after a meal. Alternatively, indinavir may be administered with a low-fat, light meal.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.
